VYNT

Vyant Bio, Inc. Common Stock
VYNT

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

VYNT was delisted on the 12th of May, 2023.

Back to rankings

17 hedge funds and large institutions have $222K invested in Vyant Bio, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $
Holders
17
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$11K
2
+$7.09K
3
+$5.81K
4
Citadel Advisors
Citadel Advisors
Florida
+$4.86K
5
UBS Group
UBS Group
Switzerland
+$1.51K

Top Sellers

1
-$113K
2
-$24K
3
-$17K
4
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
-$12K
5
TSS
Two Sigma Securities
New York
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
1
2